Trading volume for Bioptix, Inc was 0 in the last trading session. Volume was down 100.00% under the stocks average daily volume.
Investors are feeling more bearish on shares of the company looking at the change in short interest. The firm saw a rise in short interest from September 29, 2017 to October 13, 2017 of 1,020.24%. Short shares increased 116,787 over that period. The short-interest ratio decreased to 0.0 and the percentage of shorted shares was 0.03% on October 13.
The company is trading down from yesterday’s close of $0.00. Shares last traded at $7.67 quite a bit higher than the 50 day moving average which is $5.60 and which is well above the 200 day moving average of $4.26. The 50 day moving average was up $2.07 and the 200 day average was up $3.41.
Bioptix, Inc., through its subsidiary, BiOptix Diagnostics, Inc., develops enhanced Surface Plasmon Resonance (SPR) instruments. BiOptix SPR biosensors shed light on binding parameters that are required for determining whether a biologic or small molecule drug would be efficacious in humans and at what dose a drug should be administered. The company was formerly known as Venaxis, Inc. and changed its name to Bioptix, Inc. in November 2016. Bioptix, Inc. was founded in 2000 and is based in Boulder, Colorado..